Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+4.4%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$24.6B
AUM Growth
+$2.03B
(+9%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
5.09%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$168M |
| 2 |
Apple
AAPL
|
$71.3M |
| 3 |
Microsoft
MSFT
|
$57.4M |
| 4 |
HDFC Bank
HDB
|
$44.6M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
$40.5M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$83.3M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$81.2M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$43.3M |
| 4 |
Broadcom
AVGO
|
$42.7M |
| 5 |
Advanced Micro Devices
AMD
|
$37.7M |
Sector Composition
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 10.25% |
| 3 | Communication Services | 8.94% |
| 4 | Healthcare | 6.61% |
| 5 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAPP
1401
Rapport Therapeutics
RAPP
$524M
| $23.2K | ﹤0.01% |
+1,219
| New | +$23.2K |
|
|
TECX
1402
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $23.1K | ﹤0.01% |
+492
| New | +$23.1K |
|
1403
Liberty Broadband Class C
LBRDK
$8.61B
| $22.9K | ﹤0.01% |
301
-180
| -37% | -$13.7K |
|
1404
Omeros
OMER
$284M
| $22.6K | ﹤0.01% |
+1,931
| New | +$22.6K |
|
1405
Kura Oncology
KURA
$713M
| $22.5K | ﹤0.01% |
2,591
-181
| -7% | -$1.57K |
|
|
AHH
1406
Armada Hoffler Properties
AHH
$585M
| $22.4K | ﹤0.01% |
2,224
-379
| -15% | -$3.81K |
|
1407
Keros Therapeutics
KROS
$633M
| $22.2K | ﹤0.01% |
1,350
-7
| -0.5% | -$115 |
|
|
ORKA
1408
Oruka Therapeutics, Inc. Common Stock
ORKA
$612M
| $22.2K | ﹤0.01% |
+1,166
| New | +$22.2K |
|
|
BLTE
1409
Belite Bio
BLTE
$2.16B
| $22.1K | ﹤0.01% |
+357
| New | +$22.1K |
|
1410
Global E Online
GLBE
$6.07B
| $22.1K | ﹤0.01% |
405
| – | – |
|
|
GRAL
1411
GRAIL, Inc. Common Stock
GRAL
$1.33B
| $22K | ﹤0.01% |
1,120
-3
| -0.3% | -$59 |
|
1412
Envista
NVST
$3.54B
| $21.7K | ﹤0.01% |
1,130
-449
| -28% | -$8.64K |
|
1413
Entrada Therapeutics
TRDA
$201M
| $21.7K | ﹤0.01% |
+1,246
| New | +$21.7K |
|
|
CRGX
1414
DELISTED
CARGO Therapeutics
CRGX
| $21.7K | ﹤0.01% |
+1,534
| New | +$21.7K |
|
|
TIGR
1415
UP Fintech Holding
TIGR
$2.18B
| $21.7K | ﹤0.01% |
3,330
+220
| +7% | +$1.43K |
|
1416
Teradata
TDC
$1.99B
| $21.5K | ﹤0.01% |
680
-153
| -18% | -$4.84K |
|
|
BCYC
1417
Bicycle Therapeutics
BCYC
$496M
| $21.3K | ﹤0.01% |
1,466
+124
| +9% | +$1.8K |
|
1418
Mineralys Therapeutics
MLYS
$2.31B
| $21.3K | ﹤0.01% |
1,658
-141
| -8% | -$1.81K |
|
|
EH
1419
EHang Holdings
EH
$1.16B
| $21.1K | ﹤0.01% |
1,350
+53
| +4% | +$830 |
|
1420
iShares Global Infrastructure ETF
IGF
$7.99B
| $20.8K | ﹤0.01% |
41,873
-5,920
| -12% | -$2.95K |
|
|
INN
1421
Summit Hotel Properties
INN
$614M
| $20.5K | ﹤0.01% |
3,023
-1,176
| -28% | -$7.97K |
|
1422
Arbutus Biopharma
ABUS
$805M
| $20.3K | ﹤0.01% |
6,315
-513
| -8% | -$1.65K |
|
|
PLYM
1423
Plymouth Industrial REIT
PLYM
$998M
| $20.2K | ﹤0.01% |
1,140
-445
| -28% | -$7.89K |
|
1424
ACI Worldwide
ACIW
$5.19B
| $19.9K | ﹤0.01% |
383
-71
| -16% | -$3.69K |
|
1425
SITE Centers
SITC
$490M
| $19.8K | ﹤0.01% |
1,316
-8,066
| -86% | -$121K |
|